Literature DB >> 23399355

Therapy for chronic cold agglutinin disease: perspective for further improvements.

Sigbjørn Berentsen.   

Abstract

Mesh：

Substances：

Year:  2013        PMID： 23399355      PMCID： PMC3626464          DOI： 10.2450/2013.0273-12

Source DB:  PubMed          Journal:  Blood Transfus        ISSN： 1723-2007            Impact factor:   3.443


× No keyword cloud information.
  15 in total

1.  Acute phase haemolysis in chronic cold agglutinin disease.

Authors:  E Ulvestad; S Berentsen; T E Mollnes
Journal:  Scand J Immunol       Date:  2001 Jul-Aug       Impact factor: 3.487

Review 2.  Classification and therapeutic approaches in autoimmune hemolytic anemia: an update.

Authors:  Marc Michel
Journal:  Expert Rev Hematol       Date:  2011-12       Impact factor: 2.929

3.  High response rate and durable remissions following fludarabine and rituximab combination therapy for chronic cold agglutinin disease.

Authors:  Sigbjørn Berentsen; Ulla Randen; Anne Marita Vågan; Henrik Hjorth-Hansen; Anders Vik; Jakob Dalgaard; Eva-Marie Jacobsen; Aud S Thoresen; Klaus Beiske; Geir E Tjønnfjord
Journal:  Blood       Date:  2010-07-15       Impact factor: 22.113

4.  Efficacy of rituximab-bendamustine in cold agglutinin haemolytic anaemia refractory to previous chemo-immunotherapy: a case report.

Authors:  Angela Gueli; Daniela Gottardi; Huijing Hu; Irene Ricca; Alberto De Crescenzo; Corrado Tarella
Journal:  Blood Transfus       Date:  2013-01-22       Impact factor: 3.443

5.  Exclusive occurrence of K chains in isolated cold haemagglutinins.

Authors:  M Harboe; R van Furth; H Schubothe; K Lind; R S Evans
Journal:  Scand J Haematol       Date:  1965

Review 6.  Diagnosis and treatment of cold agglutinin mediated autoimmune hemolytic anemia.

Authors:  Sigbjørn Berentsen; Geir E Tjønnfjord
Journal:  Blood Rev       Date:  2012-02-12       Impact factor: 8.250

Review 7.  How I manage cold agglutinin disease.

Authors:  Sigbjørn Berentsen
Journal:  Br J Haematol       Date:  2011-03-08       Impact factor: 6.998

8.  Primary chronic cold agglutinin disease: a population based clinical study of 86 patients.

Authors:  Sigbjørn Berentsen; Elling Ulvestad; Ruth Langholm; Klaus Beiske; Henrik Hjorth-Hansen; Waleed Ghanima; Jon Hjalmar Sørbø; Geir E Tjønnfjord
Journal:  Haematologica       Date:  2006-04       Impact factor: 9.941

Review 9.  Immunological tolerance loss vs. erythrocyte self antigens and cytokine network disregulation in autoimmune hemolytic anaemia.

Authors:  Enzo Fagiolo
Journal:  Autoimmun Rev       Date:  2004-02       Impact factor: 9.754

10.  Balancing risk versus benefit in the treatment of Waldenström's Macroglobulinemia patients with nucleoside analogue-based therapy.

Authors:  Xavier Leleu; Jérome Tamburini; Aldo Roccaro; Pierre Morel; Jacob Soumerai; Vincent Lévy; Mathieu Wemeau; Sandy Balkaran; Stephanie Poulain; Zachary R Hunter; Irene M Ghobrial; Steven P Treon; Veronique Leblond
Journal:  Clin Lymphoma Myeloma       Date:  2009-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.